Guest guest Posted January 24, 2010 Report Share Posted January 24, 2010 http://www.cnn.com/2010/HEALTH/01/22/fda.approval.ms.drug/ The FDA says the drug, Ampyra (generic name dalfampridine, formerly known as fampridine), is the first MS therapy that is taken orally and the first of its kind to receive FDA approval. It is designed help people with any type of MS improve their walking speed. Haven't heard from anyone online using this med, I wonder how will it would work with LDN, I'd love to be able to walk and maybe run again. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.